The typical compounded dose range (250 to 500 mcg subcutaneously once daily) is based on empirical clinical practice, not Phase I dose-finding trials
Experimental evidence from knockout models suggests that reduced NNMT activity is associated with resistance to tumor formation, leading to speculation about a possible role for this enzyme in cancer biology
All of them are small pilot studies
Addetia A, Park YJ, Starr T, Greaney AJ, Sprouse KR, Bowen JE, et al
Recommending unapproved treatments undermines this principle and puts patients at unnecessary risk
Depois, o desafio ser alcanar o espetacular Salkantay, um dos picos mais altos do Peru, e cruzar a exuberante borda da Floresta Nublada